European Union to restrict use of controversial Cox-2 drugs

European Union to restrict use of controversial Cox-2 drugs

Cox-2 painkillers, already the focus of enormous controversy in the US, will be restricted in the European Union due to the risk of heart damage. The European Medicines Agency yesterday told doctors not to prescribe the drugs, which include Pfizer's Celebrex and Bextra, to people with heart conditions